Directorate General of Foreign Trade lifts export ban on Hydroxychloroquine API, its formulations

Directorate General of Foreign Trade (DGFT) on Thursday lifted the export ban on Hydroxychloroquine API and its formulations.

Earlier, the Union Health Ministry issued a fresh clinical management protocol for COVID-19 patients.

As per the latest protocol, the health ministry has described the use of investigational therapies--Remdesivir, Convalescent plasma, Tocilizumab, and Hydroxychloroquine (HCQ) on coronavirus patients.

( With inputs from ANI )